| Name | Title | Contact Details |
|---|
Caring Companions is a Youngwood, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ReVision Optics®, Inc., (RVO) is a privately held corporation headquartered in Southern California, USA. RVO`s main focus is developing unique optical solutions for the treatment of presbyopia. Fueled by a belief that no one should ever have to hold a menu out at arm`s length, the company developed the Raindrop® Near Vision Corneal Inlay, a unique patented refractive surgery solution. This inlay is designed to improve the near vision that has been lost by the eye`s natural aging process, called presbyopia. The Company is actively pursuing regulatory approvals and market opportunities for Raindrop® worldwide, and is committed to ridding the world of reading glasses, one satisfied patient at a time.
Panoramic Health is the nation`s leading integrated value-based kidney care platform led by physicians. The company is committed to keeping nephrologists independent, relevant, and at the center of patient-care delivery; improving outcomes and slowing disease progression for CKD-ESKD patients. Panoramic Health`s value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world`s largest clinical CKD data warehouses that enable nephrologists to deliver better patient outcomes and value-based care.
Atrium Health, previously Carolinas HealthCare System, one of the nation`s leading and most innovative healthcare organizations, provides a full spectrum of healthcare and wellness programs throughout the Southeast region. Its diverse network of care locations includes academic medical centers, hospitals, freestanding emergency departments, physician practices, surgical and rehabilitation centers, home health agencies, nursing homes and behavioral health centers, as well as hospice and palliative care services. Atrium Health works to enhance the overall health and well-being of its communities through high-quality patient care, education and research programs, and numerous collaborative partnerships and initiatives. Our mission: to improve health, elevate hope and advance healing – for all. Premier facilities include Levine Cancer Institute, Levine Children`s Hospital, Sanger Heart & Vascular Institute, and the Neurosciences Institute. Ultimately, our success is determined not by the buildings we construct, but by the investment we make in the people and programs that bring each new facility to life. We are providing a broad framework of support that enables extraordinary professionals to bring caring, commitment, integrity and teamwork to a vitally important healing mission. The motivating force behind all of this activity is fulfilling our duty to meet community needs.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.